Artivion
ISIN US2289031005
|WKN 900006
Market cap (in EUR)
1,095.57 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
Healthcare Healthcare Equipment General Medical Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 1,095.57 m |
| EPS, EUR | -0.48 |
| P/B ratio | 4.20 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 359.19 m |
| Net income, EUR | -12.33 m |
| Profit margin | -3.43% |
What ETF is Artivion in?
There are 22 ETFs which contain Artivion. All of these ETFs are listed in the table below. The ETF with the largest weighting of Artivion is the L&G Healthcare Breakthrough UCITS ETF USD Acc.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
